SSKN logo

STRATA Skin Sciences (SSKN) EBITDA

Annual EBITDA

-$3.38 M
-$4.51 M-399.65%

December 31, 2023

Summary

Performance

1-Year Change

-399.65%

3-Year Change

-22433.33%

5-Year Change

-265.52%

15-Year Change

-174.5%

SSKN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

75.54%
SSKN annual EBITDA is higher than 75.54% of companies in Healthcare sector

High & Low

All-time High

$4.54 M
SSKN annual EBITDA is currently -174.50% below its historical high of $4.54 million

3-Year Low

-$3.38 M
SSKN annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SSKN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 27, 2025
SSKN next annual earnings announcement is scheduled for Mar 27, 2025

OtherSSKNprofitabilitymetrics:

Annual Revenue

$33.36 M
SSKN annual revenue is $33.36 million

Annual Net Income

-$10.83 M
SSKN annual net profit is -$10.83 million

Annual EBIT

-$9.28 M
SSKN annual earnings before interest & taxes is -$9.28 million

Annual EPS

-$3.10
SSKN annual earnings per share is -$3.10

Quarterly EBITDA

-$265.00 K
-$2.03 M-115.05%

September 30, 2024

Summary

Performance

3-Month Change

-115.05%

1-Year Change

+82.33%

3-Year Change

+82.33%

5-Year Change

+82.33%

SSKN Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

74.03%
SSKN quarterly EBITDA is higher than 74.03% of companies in Healthcare sector

High & Low

All-time High

$2.07 M
SSKN quarterly EBITDA is currently -112.78% below its historical high of $2.07 million

3-Year Low

-$1.99 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SSKN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
SSKN next earnings announcement is scheduled for Mar 27, 2025

OtherSSKNprofitabilitymetrics:

Quarterly Revenue

$8.80 M
SSKN quarterly revenue is $8.80 million

Quarterly Net Income

-$2.12 M
SSKN quarterly net profit is -$2.12 million

Quarterly EBIT

-$1.58 M
SSKN quarterly earnings before interest & taxes is -$1.58 million

Quarterly EPS

-$0.53
SSKN quarterly earnings per share is -$0.53

TTM EBITDA

-$1.99 M
-$1.28 M-179.24%

September 30, 2024

Summary

Performance

3-Month Change

-179.24%

1-Year Change

+48.06%

3-Year Change

+48.06%

5-Year Change

+48.06%

SSKN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

74.7%
SSKN TTM EBITDA is higher than 74.7% of companies in Healthcare sector

High & Low

All-time High

$5.87 M
SSKN TTM EBITDA is currently -133.90% below its historical high of $5.87 million

3-Year Low

-$3.83 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SSKN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
SSKN next earnings announcement is scheduled for Mar 27, 2025

OtherSSKNprofitabilitymetrics:

TTM Revenue

$32.67 M
SSKN TTM revenue is $32.67 million

TTM Net Income

-$9.38 M
SSKN TTM net profit is -$9.38 million

TTM EBIT

-$7.36 M
SSKN TTM earnings before interest & taxes is -$7.36 million

TTM EPS

-$2.64
SSKN TTM earnings per share is -$2.64

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$3.38 M
SSKN annual EBITDA is -$3.38 million

Annual Net Income

-$10.83 M
SSKN annual net profit is -$10.83 million

Annual Interest Expense

$1.64 M
SSKN annual interest expense is $1.64 million

Annual Income Tax

-$92.00 K
SSKN annual income tax is -$92.00 thousand

Annual D&A

$5.90 M
SSKN annual depreciation & amortization is $5.90 million

SSKN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-399.6%+82.3%+48.1%
3 y3 years-10000.0%+82.3%+48.1%
5 y5 years-265.5%+82.3%+48.1%

SSKN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-295.6%at low-115.0%+86.7%-186.6%+48.1%
5 y5-year-286.6%at low-112.8%+86.7%-186.6%+48.1%
alltimeall time-174.5%+85.3%-112.8%+97.0%-133.9%+91.9%

STRATA Skin Sciences EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$265.00 K(-115.0%)
-$1.99 M(+179.2%)
Jun 2024
-
$1.76 M(-217.4%)
-$713.00 K(-81.4%)
Mar 2024
-
-$1.50 M(-24.5%)
-$3.83 M(+13.4%)
Dec 2023
-$3.38 M(-399.6%)
-$1.99 M(-296.2%)
-$3.38 M(-1430.7%)
Sep 2023
-
$1.01 M(-174.5%)
$254.00 K(-292.4%)
Jun 2023
-
-$1.36 M(+29.8%)
-$132.00 K(-113.6%)
Mar 2023
-
-$1.05 M(-163.6%)
$974.00 K(-13.7%)
Dec 2022
$1.13 M(-34.7%)
$1.65 M(+162.7%)
$1.13 M(<-9900.0%)
Sep 2022
-
$627.00 K(-347.8%)
-$5000.00(-80.8%)
Jun 2022
-
-$253.00 K(-71.7%)
-$26.00 K(-101.1%)
Mar 2022
-
-$893.00 K(-273.7%)
$2.30 M(+33.1%)
Dec 2021
$1.73 M(<-9900.0%)
$514.00 K(-15.2%)
$1.73 M(-8.5%)
Sep 2021
-
$606.00 K(-70.8%)
$1.89 M(+86.7%)
Jun 2021
-
$2.07 M(-241.5%)
$1.01 M(-161.3%)
Mar 2021
-
-$1.47 M(-317.4%)
-$1.65 M(>+9900.0%)
Dec 2020
-$15.00 K(-100.8%)
$674.00 K(-348.7%)
-$15.00 K(-103.8%)
Sep 2020
-
-$271.00 K(-53.8%)
$398.00 K(-64.6%)
Jun 2020
-
-$587.00 K(-447.3%)
$1.12 M(-41.6%)
Mar 2020
-
$169.00 K(-84.5%)
$1.92 M(+6.2%)
Dec 2019
$1.81 M(-11.3%)
$1.09 M(+139.4%)
$1.81 M(-5.2%)
Sep 2019
-
$454.00 K(+112.1%)
$1.91 M(-20.0%)
Jun 2019
-
$214.00 K(+282.1%)
$2.39 M(+2.4%)
Mar 2019
-
$56.00 K(-95.3%)
$2.33 M(+14.4%)
Dec 2018
$2.04 M(-55.0%)
$1.19 M(+27.3%)
$2.04 M(+33.3%)
Sep 2018
-
$932.00 K(+486.2%)
$1.53 M(-6.0%)
Jun 2018
-
$159.00 K(-167.1%)
$1.63 M(-52.7%)
Mar 2018
-
-$237.00 K(-135.1%)
$3.44 M(-24.1%)
Dec 2017
$4.54 M(+63.8%)
$676.00 K(-34.4%)
$4.54 M(-21.6%)
Sep 2017
-
$1.03 M(-47.8%)
$5.79 M(-1.5%)
Jun 2017
-
$1.98 M(+130.7%)
$5.87 M(+44.0%)
Mar 2017
-
$856.00 K(-55.6%)
$4.08 M(+47.3%)
Dec 2016
$2.77 M(-122.3%)
$1.93 M(+72.6%)
$2.77 M(+168.6%)
Sep 2016
-
$1.12 M(+516.6%)
$1.03 M(-247.1%)
Jun 2016
-
$181.00 K(-139.9%)
-$701.00 K(-92.7%)
Mar 2016
-
-$454.00 K(-341.5%)
-$9.56 M(-23.0%)
Dec 2015
-$12.42 M(-16.2%)
$188.00 K(-130.5%)
-$12.42 M(-21.5%)
Sep 2015
-
-$616.00 K(-92.9%)
-$15.82 M(-15.5%)
Jun 2015
-
-$8.68 M(+161.8%)
-$18.72 M(+32.6%)
Mar 2015
-
-$3.32 M(+3.2%)
-$14.11 M(-21.9%)
Dec 2014
-$14.83 M
-$3.21 M(-8.5%)
-$18.08 M(-4.0%)
Sep 2014
-
-$3.51 M(-13.8%)
-$18.83 M(-13.7%)
Jun 2014
-
-$4.07 M(-44.1%)
-$21.82 M(-10.1%)
DateAnnualQuarterlyTTM
Mar 2014
-
-$7.28 M(+83.9%)
-$24.26 M(+5.7%)
Dec 2013
-$22.95 M(+5.7%)
-$3.96 M(-39.1%)
-$22.95 M(-6.9%)
Sep 2013
-
-$6.50 M(-0.3%)
-$24.63 M(+6.0%)
Jun 2013
-
-$6.52 M(+9.3%)
-$23.25 M(+5.5%)
Mar 2013
-
-$5.97 M(+5.6%)
-$22.05 M(+1.7%)
Dec 2012
-$21.70 M(+9.1%)
-$5.65 M(+10.4%)
-$21.68 M(+6.2%)
Sep 2012
-
-$5.12 M(-3.8%)
-$20.43 M(-4.1%)
Jun 2012
-
-$5.32 M(-5.2%)
-$21.31 M(+3.0%)
Mar 2012
-
-$5.61 M(+27.7%)
-$20.68 M(+3.9%)
Dec 2011
-$19.90 M(+1.1%)
-$4.39 M(-26.8%)
-$19.90 M(-5.1%)
Sep 2011
-
-$6.00 M(+27.8%)
-$20.96 M(+5.9%)
Jun 2011
-
-$4.69 M(-2.7%)
-$19.79 M(+1.1%)
Mar 2011
-
-$4.82 M(-11.5%)
-$19.57 M(-0.6%)
Dec 2010
-$19.68 M(+7.7%)
-$5.45 M(+12.9%)
-$19.68 M(-0.3%)
Sep 2010
-
-$4.83 M(+8.0%)
-$19.74 M(-0.8%)
Jun 2010
-
-$4.47 M(-9.5%)
-$19.90 M(+3.5%)
Mar 2010
-
-$4.94 M(-10.3%)
-$19.22 M(+5.2%)
Dec 2009
-$18.27 M(+1.7%)
-$5.50 M(+10.2%)
-$18.27 M(+7.4%)
Sep 2009
-
-$4.99 M(+31.8%)
-$17.00 M(+4.3%)
Jun 2009
-
-$3.79 M(-4.8%)
-$16.30 M(-7.0%)
Mar 2009
-
-$3.98 M(-6.1%)
-$17.53 M(-2.4%)
Dec 2008
-$17.97 M(+39.6%)
-$4.24 M(-1.1%)
-$17.97 M(+4.8%)
Sep 2008
-
-$4.29 M(-14.6%)
-$17.14 M(+8.3%)
Jun 2008
-
-$5.02 M(+13.6%)
-$15.82 M(+12.4%)
Mar 2008
-
-$4.42 M(+29.5%)
-$14.07 M(+9.4%)
Dec 2007
-$12.87 M(+7.6%)
-$3.41 M(+14.9%)
-$12.87 M(+0.9%)
Sep 2007
-
-$2.97 M(-9.2%)
-$12.76 M(+3.5%)
Jun 2007
-
-$3.27 M(+1.7%)
-$12.33 M(+2.4%)
Mar 2007
-
-$3.22 M(-2.7%)
-$12.03 M(+1.4%)
Dec 2006
-$11.96 M(+85.7%)
-$3.30 M(+30.2%)
-$11.87 M(+6.9%)
Sep 2006
-
-$2.54 M(-14.8%)
-$11.10 M(+11.9%)
Jun 2006
-
-$2.98 M(-2.4%)
-$9.93 M(+18.9%)
Mar 2006
-
-$3.05 M(+20.4%)
-$8.35 M(+57.6%)
Dec 2005
-$6.44 M(+107.8%)
-$2.54 M(+86.4%)
-$5.30 M(+34.8%)
Sep 2005
-
-$1.36 M(-2.9%)
-$3.93 M(+23.0%)
Jun 2005
-
-$1.40 M(+20.1%)
-$3.19 M(+78.1%)
Dec 2004
-$3.10 M(+66.5%)
-$1.17 M(+86.4%)
-$1.79 M(+186.4%)
Sep 2004
-
-$626.10 K
-$626.10 K
Dec 2003
-$1.86 M(+103.5%)
-
-
Dec 2002
-$915.00 K(-66.2%)
-
-
Dec 2001
-$2.71 M(+48.3%)
-
-
Dec 2000
-$1.82 M
-
-

FAQ

  • What is STRATA Skin Sciences annual EBITDA?
  • What is the all time high annual EBITDA for STRATA Skin Sciences?
  • What is STRATA Skin Sciences annual EBITDA year-on-year change?
  • What is STRATA Skin Sciences quarterly EBITDA?
  • What is the all time high quarterly EBITDA for STRATA Skin Sciences?
  • What is STRATA Skin Sciences quarterly EBITDA year-on-year change?
  • What is STRATA Skin Sciences TTM EBITDA?
  • What is the all time high TTM EBITDA for STRATA Skin Sciences?
  • What is STRATA Skin Sciences TTM EBITDA year-on-year change?

What is STRATA Skin Sciences annual EBITDA?

The current annual EBITDA of SSKN is -$3.38 M

What is the all time high annual EBITDA for STRATA Skin Sciences?

STRATA Skin Sciences all-time high annual EBITDA is $4.54 M

What is STRATA Skin Sciences annual EBITDA year-on-year change?

Over the past year, SSKN annual EBITDA has changed by -$4.51 M (-399.65%)

What is STRATA Skin Sciences quarterly EBITDA?

The current quarterly EBITDA of SSKN is -$265.00 K

What is the all time high quarterly EBITDA for STRATA Skin Sciences?

STRATA Skin Sciences all-time high quarterly EBITDA is $2.07 M

What is STRATA Skin Sciences quarterly EBITDA year-on-year change?

Over the past year, SSKN quarterly EBITDA has changed by +$1.24 M (+82.33%)

What is STRATA Skin Sciences TTM EBITDA?

The current TTM EBITDA of SSKN is -$1.99 M

What is the all time high TTM EBITDA for STRATA Skin Sciences?

STRATA Skin Sciences all-time high TTM EBITDA is $5.87 M

What is STRATA Skin Sciences TTM EBITDA year-on-year change?

Over the past year, SSKN TTM EBITDA has changed by +$1.84 M (+48.06%)